Obtenga las últimas noticias sobre las acciones de Sana Biotechnology con actualizaciones sobre las tendencias del mercado, las finanzas y el análisis de Benzinga. Manténgase informado sobre el rendimiento de SANA

Últimas noticias sobre

SANA BIOTECHNOLOGY INC

Sana Biotechnology

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

Sana Biotechnology Inc

Sanara MedTech Inc

SANAI HEALTH IND GROUP CO by SANAI HEALTH IND GROUP CO LTD.

Sanarco Funds Inc

Sanatana Resources Inc

Health Care

Press Releases

Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes

Earnings

News

Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates

Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

IPOs

Sana Biotechnology Announces Pricing of Public Offering

Ajit Singh Appointed CEO of Harbinger Health and CEO-Partner of Flagship Pioneering

Sana Biotechnology Reports Second Quarter 2025 Financial Results and Business Updates

Financing

Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares

Biotechs Big Bang: IPOs, Uplists and the Short Squeeze Effect

Sana Biotechnology to Present at September 2025 Investor Conferences

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

FHTX

MCRB

MRNA

PPCB

RHHVF

SANA

Ardelyx

Aurinia Pharmaceuticals Inc - Common Shares

Aurinia Pharmaceuticals

BioCryst Pharmaceuticals, Inc. - Common Stock

BioCryst Pharma

Biohaven

Celldex Therapeutics, Inc. - Common Stock

Celldex Therapeutics

CureVac

Dianthus Therapeutics, Inc. - Common Stock

Dianthus Therapeutics

Dynavax Technologies Corporation - Common Stock

Dynavax Technologies

Immunocore Holdings plc - American Depositary Shares

Immunocore Holdings

Immunome

Immatics

Janux Therapeutics

MannKind

NuCana

Novavax

Oric Pharmaceuticals, Inc. - Common Stock

ORIC Pharmaceuticals

Oruka Therapeutics

Precigen

Relay Therapeutics

Sionna Therapeutics

Stoke Therapeutics

Spyre Therapeutics

Tourmaline Bio

Taysha Gene Therapies, Inc. - Common Stock

Taysha Gene Therapies

Zymeworks

Wedbush

Morgan Stanley

JMP Securities

HC Wainwright & Co.

Citizens Capital Markets

Comments

Sana Biotechnology Noticias bursátiles

Noticias

Últimas noticias sobre

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL